What is GH's market cap?

Guardant Health, Inc. (GH) is a listed stock with a live quote. The latest market cap on this page is $17.4B.

Where is Guardant Health, Inc. headquartered?

Guardant Health, Inc. is headquartered in Palo Alto, CA.

How do I get GH news from the API?

Call GET /v1/news?tickers=GH. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.

How far back does GH news go?

Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for GH, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.

Is the GH price on this page from the API?

The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Can I use the Pro plan commercially?

No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email sales@marketnewsapi.com.

GH · NASDAQ

Guardant Health, Inc.

$130.02 -38.56 (-22.87%)

Company overview

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprises a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing the LUNAR-2 test for the early detection of colorectal cancer in eligible asymptomatic individuals; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations to potentially relevant clinical trials.

Sector: Healthcare
Industry: Medical - Diagnostics & Research
Exchange: NASDAQ
Market cap: $17.4B
Employees: 1,999
Headquarters: Palo Alto, CA
Website: guardanthealth.com
CEO: Helmy Eltoukhy
Listed: October 4, 2018
P/E: -38.35
Dividend yield: 0.00%

Company financials

Revenue: $1.1B
Gross profit: $701M
Operating income: -$448M
EBITDA: -$391M
Net income: -$433M
EPS: -$3.39
Total assets: $1.9B
Total debt: $1.7B
Gross margin: 64.90%
Net margin: -40.10%
Earnings yield: -2.61%

Revenue segmentation

By product (FY 2025)

By region (FY 2025)

Showing FY 2025

Price chart

GH 1D NASDAQ O176.49H177.77L167.25C168.58-6.42 (-3.67%)Vol2.27M

News

Ticker	Type	Headline	Source	Published
GHGuardant Health, Inc.	Stock news	Guardant Health Q3 adjusted EBITDA misses estimates	Reuters	Nov 5, 4:51:16 PM ET
GHGuardant Health, Inc.	Stock news	BRIEF-Guardant Health Q3 Adjusted EPS USD -0.29 Vs. IBES Estimate USD -0.32	Reuters	Nov 5, 4:14:57 PM ET
GHGuardant Health, Inc.	Press release	Guardant Health Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance	Business Wire	Nov 5, 4:05:40 PM ET
AZN	Press release	Precision Oncology Market Size, Share, Trends, and Growth - Global Forecast to 2036 \| Market to Reach $246.58 Billion as Liquid Biopsy, NGS, and AI Drive 9.8% CAGR	GlobeNewswire	Nov 5, 11:28:46 AM ET
GHGuardant Health, Inc.	Press release	Global Multi-Cancer Early Detection (MCED) Market Size, Share, Trends and Forecast 2026-2036 \| Blood-Based Screening and AI Fuel 21.2% CAGR and $8.4 Billion Market by 2036	GlobeNewswire	Nov 5, 11:21:39 AM ET
GHGuardant Health, Inc.	Press release	TwinStrand Biosciences Announces USPTO Confirmation of Patentability of Core Duplex Sequencing Patent	Business Wire	Nov 5, 7:30:07 AM ET
GHGuardant Health, Inc.	Stock news	Countdown to Guardant Health (GH) Q3 Earnings: Wall Street Forecasts for Key Metrics	Zacks Investment Research	Nov 4, 8:15:04 AM ET
GHGuardant Health, Inc.	Press release	Kevin Sayer Joins Guardant Health Board of Directors	Business Wire	Nov 3, 4:30:00 PM ET
GHGuardant Health, Inc.	Press release	Guardant Health Wins 2026 Prix Galien USA Award for Best Medical Technology for Shield Blood Test	Business Wire	Nov 3, 8:05:00 AM ET
GHGuardant Health, Inc.	Stock news	Guardant Health (GH) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release	Zacks Investment Research	Oct 29, 11:01:41 AM ET
GHGuardant Health, Inc.	Press release	Guardant Health Applauds New Law Ensuring Access to Colorectal Cancer Screening Innovations with No Cost-Sharing for Pennsylvanians	Business Wire	Oct 29, 8:05:00 AM ET
GHGuardant Health, Inc.	Stock news	Allspring Emerging Growth Fund: Q3 2026 Top Contributors And Detractors	Seeking Alpha	Oct 28, 6:50:00 AM ET
GHGuardant Health, Inc.	Stock news	This Guardant Health Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday	Benzinga	Oct 23, 8:37:19 AM ET
GHGuardant Health, Inc.	Press release	Guardant Health Highlights Broad Liquid Biopsy Research Portfolio at ESMO Congress 2026	Business Wire	Oct 20, 9:02:00 AM ET
GHGuardant Health, Inc.	Stock news	The AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are Winning	MarketBeat	Oct 19, 10:31:14 AM ET
GHGuardant Health, Inc.	Press release	TwinStrand Biosciences Announces Second U.S. Patent Trial and Appeal Board Decision Upholding All Claims of TwinStrand’s ‘127 Patent	Business Wire	Oct 15, 4:01:00 PM ET
GHGuardant Health, Inc.	Stock news	Guardant Health Shield Blood Test Demonstrates Leading Screening Adherence and CRC Deaths Averted Compared to Stool-Based Tests	GuruFocus	Oct 15, 9:00:00 AM ET
GHGuardant Health, Inc.	Press release	Guardant Health Shield Blood Test Demonstrates Leading Screening Adherence and CRC Deaths Averted Compared to Stool-Based Tests	Business Wire	Oct 15, 8:05:00 AM ET
GHGuardant Health, Inc.	Stock news	Reviewing The Pennant Group (NASDAQ:PNTG) and Guardant Health (NASDAQ:GH)	Defense World	Oct 15, 2:29:06 AM ET
GHGuardant Health, Inc.	Press release	Guardant Health Announces Approval in Europe of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced ER-positive Breast Cancer	Business Wire	Oct 8, 4:12:00 PM ET

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.